# Sofinnova Investments, Inc. 13F Q2 2026: $1.9 billion

Sofinnova Investments, Inc. reported $1.9 billion in 13F securities across 57 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Natera Inc at $421 million, 21.8% of the reported value. Since Q1 2026 it opened 13 new positions and exited 30.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $1,934,262,135
- Positions: 57
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1631134
- Form 13F file number: 028-18774
- Business address: 3000 Sand Hill Road BUILDING 3-SUITE 150, Menlo Park, CA 94025
- SEC filing: [0001104659-26-096982](https://www.sec.gov/Archives/edgar/data/1631134/000110465926096982/0001104659-26-096982-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/sofinnova-investments-inc-160297)

## Top 25 holdings by value

The largest of 57 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 1,550,280 | $420.8 million | No change |
| [Vera Therapeutics Inc](https://specstream.ai/data/institutional-holders/vera-therapeutics-inc-92337r101) | CL A | 2,793,987 | $119.9 million | No change |
| [Genmab A/S](https://specstream.ai/data/institutional-holders/genmab-a-s-372303206) | SPONSORED ADS | 4,045,215 | $111.1 million | +3,292,954 |
| [Jazz Pharmaceuticals PLC](https://specstream.ai/data/institutional-holders/jazz-pharmaceuticals-plc-g50871105) | SHS USD | 365,341 | $88 million | -232,986 |
| [Rapport Therapeutics Inc](https://specstream.ai/data/institutional-holders/rapport-therapeutics-inc-75383l102) | COM | 1,904,408 | $79.4 million | No change |
| [Seaport Therapeutics Inc](https://specstream.ai/data/institutional-holders/seaport-therapeutics-inc-81221k108) | COMMON STOCK | 3,564,871 | $77.4 million | New |
| [Arrivent Biopharma Inc](https://specstream.ai/data/institutional-holders/arrivent-biopharma-inc-04272n102) | COM | 1,696,752 | $58.9 million | No change |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 1,717,505 | $57.3 million | -1,428,383 |
| [Bioage Labs Inc](https://specstream.ai/data/institutional-holders/bioage-labs-inc-09077v100) | COM | 2,293,788 | $56.2 million | No change |
| [Bristol-Myers Squibb Co](https://specstream.ai/data/institutional-holders/bristol-myers-squibb-co-110122108) | COM | 876,970 | $50.5 million | -1,111,751 |
| [Supernus Pharmaceuticals](https://specstream.ai/data/institutional-holders/supernus-pharmaceuticals-868459108) | COM | 1,036,328 | $48.2 million | +82,019 |
| [Rhythm Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/rhythm-pharmaceuticals-inc-76243j105) | COM | 408,027 | $45.3 million | -42,069 |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 343,100 | $43.3 million | New |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 76,489 | $41.4 million | -83,581 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 1,035,148 | $40.1 million | -1,078,403 |
| [Axsome Therapeutics Inc.](https://specstream.ai/data/institutional-holders/axsome-therapeutics-inc-05464t104) | COM | 160,429 | $39.3 million | -52,318 |
| [Immatics N.V](https://specstream.ai/data/institutional-holders/immatics-n-v-n44445109) | SHS | 3,669,346 | $37.2 million | +38,892 |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 1,658,384 | $36.8 million | +24,487 |
| [Immunome Inc](https://specstream.ai/data/institutional-holders/immunome-inc-45257u108) | COM | 1,720,316 | $36.5 million | +18,412 |
| [Ideaya Biosciences Inc](https://specstream.ai/data/institutional-holders/ideaya-biosciences-inc-45166a102) | COM | 925,119 | $34.5 million | -206,667 |
| [Anaptysbio Inc](https://specstream.ai/data/institutional-holders/anaptysbio-inc-032724106) | COM | 493,536 | $33.3 million | +245,283 |
| [Nektar Therapeutics](https://specstream.ai/data/institutional-holders/nektar-therapeutics-640268306) | COM NEW | 471,763 | $32.9 million | -37,783 |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 881,299 | $30.5 million | +62,971 |
| [Arcus Biosciences Inc](https://specstream.ai/data/institutional-holders/arcus-biosciences-inc-03969f109) | COM | 945,690 | $29.2 million | +22,604 |
| [Inhibrx Biosciences Inc](https://specstream.ai/data/institutional-holders/inhibrx-biosciences-inc-45720n103) | COM | 303,103 | $28.7 million | -102,926 |

## New positions in Q2 2026

13 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Seaport Therapeutics Inc](https://specstream.ai/data/institutional-holders/seaport-therapeutics-inc-81221k108) | COMMON STOCK | 3,564,871 | $77.4 million |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 343,100 | $43.3 million |
| Intuitive Surgical Inc | COM NEW (call) | 40,000 | $15.9 million |
| Globus Med Inc | CL A (call) | 200,000 | $15.8 million |
| [Nurix Therapeutics Inc](https://specstream.ai/data/institutional-holders/nurix-therapeutics-inc-67080m103) | COM | 524,098 | $12.7 million |
| [Design Therapeutics Inc](https://specstream.ai/data/institutional-holders/design-therapeutics-inc-25056l103) | COM | 865,135 | $12.5 million |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 565,199 | $11.4 million |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 122,998 | $11.2 million |
| [Sionna Therapeutics Inc](https://specstream.ai/data/institutional-holders/sionna-therapeutics-inc-829401108) | COM | 144,432 | $6.4 million |
| [Absci Corporation](https://specstream.ai/data/institutional-holders/absci-corporation-00091e109) | COM | 337,400 | $3.9 million |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 166,667 | $1.3 million |
| [Aktis Oncology Inc](https://specstream.ai/data/institutional-holders/aktis-oncology-inc-01021m104) | COM | 32,436 | $1 million |
| [Heartflow Inc](https://specstream.ai/data/institutional-holders/heartflow-inc-42238d107) | COM | 5,079 | $149,018 |

## Positions exited in Q2 2026

30 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Ishares TR | RUSSELL 2000 ETF (put) | 600,000 | $148.8 million |
| SPDR Series Trust | ST STR SP BIOT (put) | 1,050,000 | $134.1 million |
| [Astrazeneca PLC](https://specstream.ai/data/institutional-holders/astrazeneca-plc-g0593m107) | ORD | 456,031 | $89.9 million |
| Invesco QQQ TR | UNIT SER 1 (put) | 150,000 | $86.6 million |
| Ishares TR | ISHARES BIOTECH (put) | 475,000 | $80.2 million |
| United Therapeutics Corp Del | COM (put) | 80,300 | $47.6 million |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 229,521 | $42.1 million |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 366,175 | $41.8 million |
| Celcuity Inc | COM (put) | 300,000 | $34.2 million |
| Axsome Therapeutics Inc. | COM (put) | 200,000 | $33.8 million |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 409,183 | $30.4 million |
| [Dexcom Inc](https://specstream.ai/data/institutional-holders/dexcom-inc-252131107) | COM | 393,576 | $24.7 million |
| Pfizer Inc | COM (call) | 800,000 | $22.5 million |
| Liquidia Corporation | COM NEW (put) | 500,000 | $18.9 million |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 305,216 | $17.7 million |
| [Stryker Corporation](https://specstream.ai/data/institutional-holders/stryker-corporation-863667101) | COM | 44,480 | $14.6 million |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 477,995 | $13.2 million |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 2,056,161 | $10.9 million |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 679,578 | $8.6 million |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 395,081 | $8.3 million |
| Replimune Group Inc | COM (call) | 1,015,400 | $7.8 million |
| [Axogen Inc](https://specstream.ai/data/institutional-holders/axogen-inc-05463x106) | COM | 210,665 | $7 million |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 91,791 | $6 million |
| [Harmony Biosciences Hldgs in](https://specstream.ai/data/institutional-holders/harmony-biosciences-hldgs-in-413197104) | COM | 152,695 | $4.3 million |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 50,600 | $2.9 million |

## Also on SpecStream

- [Sofinnova Investments, Inc. Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1631134/000110465926096982/0001104659-26-096982-index.htm)
- [Sofinnova Investments, Inc. investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/sofinnova-investments-inc-160297)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Menlo Park, California

- [Scientific laboratories in Menlo Park, California](https://specstream.ai/data/businesses/scientific-laboratories/menlo-park-california-united-states)
- [Business consulting firms in Menlo Park, California](https://specstream.ai/data/businesses/business-consulting-firms/menlo-park-california-united-states)
- [Investment management firms in Menlo Park, California](https://specstream.ai/data/businesses/investment-management-firms/menlo-park-california-united-states)
- [Law firms in Menlo Park, California](https://specstream.ai/data/businesses/law-firms/menlo-park-california-united-states)
- [Real estate firms in Menlo Park, California](https://specstream.ai/data/businesses/real-estate-firms/menlo-park-california-united-states)
- [Software development companies in Menlo Park, California](https://specstream.ai/data/businesses/software-development-companies/menlo-park-california-united-states)
